6th Annual Updates from ASH 2020: Practice Changing Abstracts

February 19, 2021
Our goal is to join community-based providers and academic oncologists to improve the care and outcomes of patients with hematologic malignancies. In order to reach this goal, this conference will address early treatment options and medical advances that can be implemented in an effort to reduce cancer-related deaths. Our overarching goal is to help all healthcare professionals who are involved in the care of patients with hematologic malignancies stay abreast of the latest scientific updates, innovative ideas, and timeliest issues related to their care. This conference will provide the target audience with information that can help improve patient management and care strategies. Participants will discuss with content experts rapidly evolving developments, discover new treatments for patients, and improve overall practice paradigms. We will educate and empower community-based oncologists on best practices for treating hematologic cancers and inform them of the indicators for when to refer a patient for tertiary level care.

We are excited to welcome Courtney DiNardo, MD, MSCE to present the keynote lecture on clinical updates in myeloid malignancies. She has most recently been honored by the American Society of Hematology (ASH) as a 2020 Ernest Beutler Lecture and Prize recipient for her clinical trial contributions supporting several acute myeloid leukemia therapies.
 
Learn more at the conference website!
American Board of Pediatrics

Target Audience

This activity is designed for physicians and other healthcare professionals dedicated to the treatment of hematologic cancers.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Illustrate how cutting-edge data presented at the 2020 Annual Meeting of the American Society of Hematology (ASH) can apply to clinical practice, addressing best practices and guidelines;
  • State the emerging treatment strategies for patients with low-risk and high-risk myeloid malignancies;
  • Discuss the optimal patient selection, timing, and regimen for transplant;
  • Evaluate clinical trial data in the context of CAR T-cell therapy and its place in evolving hematologic malignancy treatment standards;
  • Choose the optimal treatment, sequencing, and supportive care strategies for patients with lymphoma using evidence-based guidelines;
  • Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
  • Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common benign hematologic diseases.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
219-465-1115
Summary
Available credit: 
  • 5.25 ABIM
  • 5.25 ABPeds
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Participation
Event starts: 
02/19/2021 - 10:30am
Event ends: 
02/19/2021 - 5:45pm
Activity opens: 
02/19/2021
Activity expires: 
06/23/2021


*Agenda subject to change.

Virtual Conference
WANT TO KNOW MORE?

Learn more about the conference by visiting the conference website here!

Questions?
Contact Meeting Achievements via e-mail here.


ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via e-mail via at support@meetingachievements.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

COURSE DIRECTOR
Michael R. Bishop, MD  Michael Bishop, MD
  Professor of Medicine
  Director, Hematopoietic Stem Cell Transplantation Program
  University of Chicago
 
 
GUEST SPEAKER
Courtney DiNardo, MD, MSCE
Associate Professor, Department of Leukemia, Division of Cancer Medicine
MD Anderson Cancer Center
 
UNIVERSITY OF CHICAGO FACULTY
Benjamin A. Derman, MD
Assistant Professor of Medicine
Adam Duvall, MD, MPH
Assistant Professor of Medicine
Andrzej Jakubowiak, MD, PhD
Professor of Medicine
Director, Myeloma Program
Satyajit Kosuri, MD
Assistant Professor of Medicine
Olatoyosi Odenike, MD
Professor of Medicine
Peter A. Riedell, MD
Assistant Professor of Medicine
Sonali M. Smith, MD
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
Elwood V. Jensen Professor in Medicine
Michael J. Thirman, MD
Associate Professor of Medicine

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
American Board of Pediatrics MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
 
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.


Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.

VIRTUAL EXHIBIT OPPORTUNITIES AVAILABLE!
This conference offers a tremendous opportunity to highlight your company products, services, and achievements in front of a wide array of key decision makers. Increase your company profile by participating as an exhibitor at this exciting event.
 
We are pleased to provide the following virtual opportunities for organizations to advertise their products and services to conference participants. Whether you are live chatting with an attendee about the elements on your exhibit page, connecting with physicians during one of the scheduled breaks, or gaining brand recognition for your company through program acknowledgements, your message will reach physicians, nurses, and other healthcare professionals.
 
Download the prospectus here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
 

Chicago Winter

REGISTRATION

Click the button below to register. Early registration rates expire January 19, 2021!

 
Profession Type
Early Registration
Regular Rate
Physicians
$30
$40
Nurses, Nurse Practitioners, Doctor of Pharmacy
$20
$30
Residents & Fellows with verification letter
$0
$0
 
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $25 administrative fee will be refunded when written notification is received by January 19, 2021. No refunds will be made after January 19, 2021.

 


CLAIMING CREDIT

After creating an account or logging in, enter the access code to unlock the credit claiming process.

Please login or create an account to proceed.